On 11/14/23, NovoCure Ltd (NASDAQ: NVCR) stock enjoyed a major increase of 12.5%, closing at $12.80. Relative to the market the stock has been extremely weak over the last nine months and has declined -0.6% during the last week.
Current PriceTarget Research Rating
NVCR is expected to continue to be Value Creation neutral reflecting capital returns that are forecasted to be in line with the cost of capital.
NovoCure has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects highly consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. NovoCure has a very low Appreciation Score of 9 and a very low Power Rating of 1, and the Lowest Value Trend Rating results.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment